Global Primary Biliary Cirrhosis Drug Market Professional Survey Report 2018
- QYR2452644
- 103 Pages
- February 2018
- Pharmaceuticals
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
By Application, the market can be split into
Clinic
Hospital
Others
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Primary Biliary Cirrhosis Drug Market Professional Survey Report 2017
1 Industry Overview of Primary Biliary Cirrhosis Drug
1.1 Definition and Specifications of Primary Biliary Cirrhosis Drug
1.1.1 Definition of Primary Biliary Cirrhosis Drug
1.1.2 Specifications of Primary Biliary Cirrhosis Drug
1.2 Classification of Primary Biliary Cirrhosis Drug
1.2.1 Budesonide
1.2.2 FFP-104
1.2.3 GSK-2330672
1.2.4 MBX-8025
1.2.5 NGM-282
1.2.6 Others
1.3 Applications of Primary Biliary Cirrhosis Drug
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug
2.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
2.4 Industry Chain Structure of Primary Biliary Cirrhosis Drug
3 Technical Data and Manufacturing Plants Analysis of Primary Biliary Cirrhosis Drug
3.1 Capacity and Commercial Production Date of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
4 Global Primary Biliary Cirrhosis Drug Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Primary Biliary Cirrhosis Drug Capacity and Growth Rate Analysis
4.2.2 2016 Primary Biliary Cirrhosis Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Primary Biliary Cirrhosis Drug Sales and Growth Rate Analysis
4.3.2 2016 Primary Biliary Cirrhosis Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Primary Biliary Cirrhosis Drug Sales Price
4.4.2 2016 Primary Biliary Cirrhosis Drug Sales Price Analysis (Company Segment)
5 Primary Biliary Cirrhosis Drug Regional Market Analysis
5.1 North America Primary Biliary Cirrhosis Drug Market Analysis
5.1.1 North America Primary Biliary Cirrhosis Drug Market Overview
5.1.2 North America 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
5.1.4 North America 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
5.2 China Primary Biliary Cirrhosis Drug Market Analysis
5.2.1 China Primary Biliary Cirrhosis Drug Market Overview
5.2.2 China 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
5.2.4 China 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
5.3 Europe Primary Biliary Cirrhosis Drug Market Analysis
5.3.1 Europe Primary Biliary Cirrhosis Drug Market Overview
5.3.2 Europe 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
5.3.4 Europe 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
5.4 Southeast Asia Primary Biliary Cirrhosis Drug Market Analysis
5.4.1 Southeast Asia Primary Biliary Cirrhosis Drug Market Overview
5.4.2 Southeast Asia 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
5.4.4 Southeast Asia 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
5.5 Japan Primary Biliary Cirrhosis Drug Market Analysis
5.5.1 Japan Primary Biliary Cirrhosis Drug Market Overview
5.5.2 Japan 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
5.5.4 Japan 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
5.6 India Primary Biliary Cirrhosis Drug Market Analysis
5.6.1 India Primary Biliary Cirrhosis Drug Market Overview
5.6.2 India 2012-2017E Primary Biliary Cirrhosis Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Primary Biliary Cirrhosis Drug Sales Price Analysis
5.6.4 India 2016 Primary Biliary Cirrhosis Drug Market Share Analysis
6 Global 2012-2017E Primary Biliary Cirrhosis Drug Segment Market Analysis (by Type)
6.1 Global 2012-2017E Primary Biliary Cirrhosis Drug Sales by Type
6.2 Different Types of Primary Biliary Cirrhosis Drug Product Interview Price Analysis
6.3 Different Types of Primary Biliary Cirrhosis Drug Product Driving Factors Analysis
6.3.1 Budesonide of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
6.3.2 FFP-104 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
6.3.3 GSK-2330672 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
6.3.4 MBX-8025 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
6.3.5 NGM-282 of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
6.3.6 Others of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
7 Global 2012-2017E Primary Biliary Cirrhosis Drug Segment Market Analysis (by Application)
7.1 Global 2012-2017E Primary Biliary Cirrhosis Drug Consumption by Application
7.2 Different Application of Primary Biliary Cirrhosis Drug Product Interview Price Analysis
7.3 Different Application of Primary Biliary Cirrhosis Drug Product Driving Factors Analysis
7.3.1 Clinic of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
7.3.2 Hospital of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
7.3.3 Others of Primary Biliary Cirrhosis Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Primary Biliary Cirrhosis Drug
8.1 AlbireoPharma
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 AlbireoPharma 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 AlbireoPharma 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.2 CymaBay Therapeutics, Inc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 CymaBay Therapeutics, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 CymaBay Therapeutics, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.3 Dr. Falk Pharma GmbH
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Dr. Falk Pharma GmbH 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Dr. Falk Pharma GmbH 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.4 Enanta Pharmaceuticals, Inc.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Enanta Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Enanta Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.5 GlaxoSmithKline Plc
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 GlaxoSmithKline Plc 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 GlaxoSmithKline Plc 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.6 Intercept Pharmaceuticals, Inc.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Intercept Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Intercept Pharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.7 Johnson & Johnson
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Johnson & Johnson 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Johnson & Johnson 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.8 MediGene AG
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 MediGene AG 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 MediGene AG 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.9 NGM Biopharmaceuticals, Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 NGM Biopharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 NGM Biopharmaceuticals, Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
8.10 Virobay Inc.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Virobay Inc. 2016 Primary Biliary Cirrhosis Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Virobay Inc. 2016 Primary Biliary Cirrhosis Drug Business Region Distribution Analysis
9 Development Trend of Analysis of Primary Biliary Cirrhosis Drug Market
9.1 Global Primary Biliary Cirrhosis Drug Market Trend Analysis
9.1.1 Global 2017-2022 Primary Biliary Cirrhosis Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Primary Biliary Cirrhosis Drug Sales Price Forecast
9.2 Primary Biliary Cirrhosis Drug Regional Market Trend
9.2.1 North America 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
9.2.2 China 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
9.2.3 Europe 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
9.2.5 Japan 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
9.2.6 India 2017-2022 Primary Biliary Cirrhosis Drug Consumption Forecast
9.3 Primary Biliary Cirrhosis Drug Market Trend (Product Type)
9.4 Primary Biliary Cirrhosis Drug Market Trend (Application)
10 Primary Biliary Cirrhosis Drug Marketing Type Analysis
10.1 Primary Biliary Cirrhosis Drug Regional Marketing Type Analysis
10.2 Primary Biliary Cirrhosis Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Primary Biliary Cirrhosis Drug by Region
10.4 Primary Biliary Cirrhosis Drug Supply Chain Analysis
11 Consumers Analysis of Primary Biliary Cirrhosis Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Primary Biliary Cirrhosis Drug Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
Figure Picture of Primary Biliary Cirrhosis Drug
Table Product Specifications of Primary Biliary Cirrhosis Drug
Table Classification of Primary Biliary Cirrhosis Drug
Figure Global Production Market Share of Primary Biliary Cirrhosis Drug by Type in 2016
Figure Budesonide Picture
Table Major Manufacturers of Budesonide
Figure FFP-104 Picture
Table Major Manufacturers of FFP-104
Figure GSK-2330672 Picture
Table Major Manufacturers of GSK-2330672
Figure MBX-8025 Picture
Table Major Manufacturers of MBX-8025
Figure NGM-282 Picture
Table Major Manufacturers of NGM-282
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Primary Biliary Cirrhosis Drug
Figure Global Consumption Volume Market Share of Primary Biliary Cirrhosis Drug by Application in 2016
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Primary Biliary Cirrhosis Drug by Regions
Figure North America Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
Figure China Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
Figure Europe Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
Figure Japan Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
Figure India Primary Biliary Cirrhosis Drug Market Size (Million USD) (2012-2022)
Table Primary Biliary Cirrhosis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug in 2016
Figure Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
Figure Industry Chain Structure of Primary Biliary Cirrhosis Drug
Table Capacity and Commercial Production Date of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Primary Biliary Cirrhosis Drug 2012-2017
Figure Global 2012-2017E Primary Biliary Cirrhosis Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Primary Biliary Cirrhosis Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Primary Biliary Cirrhosis Drug Capacity and Growth Rate
Table 2016 Global Primary Biliary Cirrhosis Drug Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate
Table 2016 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
Table 2016 Global Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
Figure North America 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
Figure North America 2016 Primary Biliary Cirrhosis Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
Figure China 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
Figure China 2016 Primary Biliary Cirrhosis Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
Figure Europe 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
Figure Europe 2016 Primary Biliary Cirrhosis Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
Figure Southeast Asia 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Primary Biliary Cirrhosis Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
Figure Japan 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
Figure Japan 2016 Primary Biliary Cirrhosis Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Primary Biliary Cirrhosis Drug 2012-2017E
Figure India 2012-2017E Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs)
Figure India 2016 Primary Biliary Cirrhosis Drug Sales Market Share
Table Global 2012-2017E Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type
Table Different Types Primary Biliary Cirrhosis Drug Product Interview Price
Table Global 2012-2017E Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application
Table Different Application Primary Biliary Cirrhosis Drug Product Interview Price
Table AlbireoPharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 AlbireoPharma Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AlbireoPharma Primary Biliary Cirrhosis Drug Business Region Distribution
Table CymaBay Therapeutics, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
Table Dr. Falk Pharma GmbH Information List
Table Product A Overview
Table Product B Overview
Table 2015 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Business Region Distribution
Table Enanta Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
Table GlaxoSmithKline Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Business Region Distribution
Table Intercept Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Johnson & Johnson Primary Biliary Cirrhosis Drug Business Region Distribution
Table MediGene AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 MediGene AG Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 MediGene AG Primary Biliary Cirrhosis Drug Business Region Distribution
Table NGM Biopharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
Table Virobay Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Virobay Inc. Primary Biliary Cirrhosis Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Virobay Inc. Primary Biliary Cirrhosis Drug Business Region Distribution
Figure Global 2017-2022 Primary Biliary Cirrhosis Drug Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Primary Biliary Cirrhosis Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Primary Biliary Cirrhosis Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Primary Biliary Cirrhosis Drug by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Primary Biliary Cirrhosis Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Primary Biliary Cirrhosis Drug by Region
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
